Obizur EU PASS. Prospective and retrospective, non-interventional study to evaluate the safety and effectiveness of Obizur in real-life practice.
Research Grant
Administered By
Medicine, Hematology
Awarded By
Baxalta, Inc.
Start Date
December 13, 2019
End Date
October 14, 2022
Administered By
Medicine, Hematology
Awarded By
Baxalta, Inc.
Start Date
December 13, 2019
End Date
October 14, 2022